Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.02
-2.39%
After-hours: Aug 15, 2025, 07:33 PM EDT

Coherus BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
297.77M -56.57M -50.7M -10.75M -12.92M 102.88M -79.65M -39.64M -42.87M -75.73M -58.87M -86.65M -50.15M -96.08M -45.73M -38.53M -29.9M -172.95M
Depreciation & Amortization
1.02M 1.05M 1.03M 1.55M 1.19M 1.51M 1.06M 899K 880K 949K 1.05M 995K 887K 767K 836K 892K 877K 849K
Stock-Based Compensation
5.42M 5.37M 6.38M 6.87M 7.23M 7.32M 10.8M 9.95M 10.08M 12.28M 11.73M 12.28M 13.85M 12.88M 10.95M 11.94M 11.6M 16.88M
Other Working Capital
-70.48M -30.83M -1.68M -41.37M -34.73M -9.12M 63M 60.12M 40.65M -26.94M -27.63M 15.1M -2.98M -24.9M 4.86M -11.22M 19.14M 904K
Other Non-Cash Items
-327.18M 13.47M 17.35M 3.2M -10.03M -147.09M 118.05M 1.24M 468K 3.11M 754K 27.59M 1.6M 45.51M 2.1M 1.64M -7.39M 146.7M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -69.56M 874K -1.24M n/a n/a n/a n/a n/a 127K 5.45M 370K 3.49M
Change in Working Capital
-23.65M 10.86M 54.54M -62.89M 74.26M -11.38M 6.37M -27.62M -6.23M -9.35M -54.61M 8.69M -16.22M -17.12M -20.61M 32.32M 24.26M 6.39M
Operating Cash Flow
-46.63M -25.83M 28.61M -62.02M 59.73M -46.77M -12.94M -54.3M -38.91M -68.73M -99.95M -37.09M -50.04M -54.05M -52.32M 13.71M -188K 1.37M
Capital Expenditures
n/a n/a n/a n/a n/a n/a -34K n/a -100K -152K -87K -457K -880K -615K -468K -261K -415K -145K
Cash Acquisitions
n/a n/a -12.5M n/a 227.82M n/a n/a 151K 440K 178K n/a n/a n/a n/a 468K 261K n/a n/a
Purchase of Investments
-20.73M n/a n/a n/a n/a n/a n/a n/a -19.51M -178K -127.38M n/a n/a n/a -10.71M -31.45M n/a -140.33M
Sales Maturities Of Investments
n/a n/a n/a n/a 227.82M 14.89M 36.21M 43.4M 60.53M 17.5M n/a n/a n/a n/a 118.66M 47.7M n/a n/a
Other Investing Acitivies
483.36M -17.49M 11.96M 444K -427.99M 187.88M -975K 7M 41.47M 178K -2.43M -457K -880K -35M -468K -261K 24M -145M
Investing Cash Flow
462.64M -17.49M -542K 444K 27.66M 202.76M 35.2M 50.55M 41.37M 17.53M -129.9M -457K -880K -35.62M 107.49M 15.99M 23.59M -285.48M
Debt Repayment
-233.19M n/a 186.91M -141K -186.77M n/a n/a n/a n/a n/a n/a 49.49M n/a 440K n/a n/a n/a n/a
Common Stock Repurchased
n/a -264K n/a n/a n/a n/a n/a n/a n/a n/a n/a -321K -642K -2.66M -23K n/a n/a -1.73M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-48.34M n/a -186.89M -16K 558K -620K 692K -332K 774K -3.03M 235K -301K 721K 363K 1.51M 1.1M 46.85M 2.44M
Financial Cash Flow
-281.52M -264K 231K -167K -187.93M 887K 366K 11.11M 54.33M 3.8M 6.59M 48.87M 721K -1.85M 1.49M 1.1M 46.85M 2.44M
Net Cash Flow
134.48M -43.58M 28.3M -61.55M -100.53M 156.88M 22.18M 7.35M 56.77M -47.4M -223.26M 11.32M -50.2M -91.52M 56.66M 30.8M 70.25M -281.67M
Free Cash Flow
-46.63M -25.83M 28.61M -62.02M 59.73M -46.77M -12.97M -54.3M -39.02M -68.88M -100.04M -37.55M -50.92M -54.66M -52.79M 13.45M -603K 1.22M